Alvogen - The New World Of Specialty Generic Drugs - Alvogen is focused exclusively on the development, production and marketing of specialty generic products.

Alvogen is carving a leadership position in an emerging “third” category of prescription drugs beside branded pharmaceuticals and commoditized generics. A new company with a rich heritage and access to an extensive portfolio, pipeline and resources, Alvogen is focused exclusively on the development, production and marketing of specialty generic products. We invite you to learn more about the special world of Alvogen.

We aspire to lead and define the ever-evolving convergence between generics and specialty pharmaceuticals. By providing greater access to such medications, we hope to improve the health and quality of life for millions of Americans.

As we pursue our vision, Alvogen’s assets include full-service manufacturing of Rx and OTC products with a sterling reputation for quality, multinational affiliates producing and marketing over 400 generic and OTC products in Europe, the Middle East and Africa, and a strong financial foundation through our private equity partner.

Expand our US specialty generics business through investment in our sustainable pipeline of high-technology products and the ongoing creation and nurturing of our strategic alliances and partnerships across the globe.